What is the concentration in mg per milliliter when 20 mg of retatrutide is diluted in 350 mL of normal saline?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Retatrutide Concentration Calculation

When 20 mg of retatrutide is diluted in 350 mL of normal saline, the final concentration is approximately 0.057 mg/mL.

Calculation Method

The concentration is determined by dividing the total drug amount by the total volume:

  • Total retatrutide: 20 mg
  • Total volume: 350 mL
  • Concentration: 20 mg ÷ 350 mL = 0.057 mg/mL (or approximately 0.06 mg/mL when rounded)

Clinical Context

While the provided evidence focuses on retatrutide's clinical efficacy for obesity and type 2 diabetes rather than dilution calculations, the pharmacokinetic studies demonstrate that retatrutide is administered subcutaneously in doses ranging from 0.5 mg to 12 mg weekly 1, 2. The dilution you're describing (20 mg in 350 mL) would be unusual for standard subcutaneous administration and may represent a preparation for a different route or research protocol.

Important Considerations

  • Verify the intended route: Retatrutide in clinical trials has been administered subcutaneously at much smaller volumes 1, 2, 3
  • Stability concerns: Like other peptide medications, retatrutide's stability after dilution should be confirmed, as many compounds become unstable after reconstitution 4, 5
  • Aseptic technique: If preparing this dilution, maintain strict sterile technique throughout the process 5

The mathematical answer remains 0.057 mg/mL, but clinical application should be verified against the specific protocol or prescribing information for your intended use.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.